ArticleIndian dermatology online journal

A Real-World Study of Tofacitinib in Indian Patients with Refractory Moderate-to-Severe Atopic Dermatitis, its Economic Considerations and Immunological Rationale.

Kabir Sardana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.